Corrigendum to "Telomerase activity in fine needle aspiration biopsy samples: Application to diagnosis of human thyroid carcinoma" [Clinica Chimica Acta 370 (2006) 180-184] (DOI:10.1016/j.cca.2006.02.009);Telomerase activity in fine needle aspiration biopsy samples: Application to diagnosis of human thyroid carcinoma

Clinica Chimica Acta

Volumn 370, Issue 1-2, 2006, Pages 180-184

  Guerra, L N ^a,d   Miler, E A ^b,d   Moiguer, S ^a   Karner, M ^a   Orlandi, A M ^c   Fideleff, H ^c   Burdman, J A ^a  

^a Hospital Israelita   (Argentina)

^b ORT Argentina   (Argentina)

^c Hospital General De Agudos Teodoro Alvarez   (Argentina)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Fine needle aspiration biopsy; Telomerase; Thyroid cancer

Indexed keywords

TELOMERASE;

ARTICLE; ASPIRATION BIOPSY; CANCER CYTODIAGNOSIS; CELL LABELING; CONTROLLED STUDY; CYTOPATHOLOGY; ENZYME ACTIVITY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SAMPLE SIZE; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; TISSUE SECTION;

EID: 33746078852     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.05.022     Document Type: Erratum

References (34)

1. Ridgway E.C. Clinical review 30: clinician's evaluation of a solitary thyroid nodule. J Clin Endocrinol Metab 74 (1992) 231-235
2. Robbins J., Merino M.J., Boice J.D., et al. Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med 115 (1991) 133-147
3. Caruso D., and Mazzaferri E.L. Fine needle aspiration biopsy in the management of thyroid nodules. Endocrinology 1 (1991) 194-202
4. Gharib H., and Goeller J.R. Fine needle aspiration biopsy of thyroid: an appraisal. Ann Intern Med 118 (1993) 282-289
5. Solomon D. Fine needle aspiration biopsy of the thyroid: an update. Thyroid Today 16 (1993) 1-9
6. Liou M.J., Chan E.C., Lin J.D., Liu F.H., and Chao T.C. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasm. Cancer Lett 191 (2003) 223-227
7. Lin J.D., Hsueh C., Chao T.C., Weng H.F., and Huang B.Y. Thyroid follicular neoplasms diagnosed by high resolution ultrasonography with fine needle aspiration cytology. Acta Cytol 41 (1997) 687-691
8. Kammori M., Nakamura K., Hashimoto M., Ogawa T., Kaminishi M., and Takubo K. Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization. Int J Oncol 22 (2003) 985-991
9. Fagin J., Matsuo K., Karmakar A., Chen D., Tang S., and Koeffler H. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 91 (1993) 179-184
10. Jossart G., Epstein H., Shaver J., et al. Immunocytochemical detection of p53 in human thyroid carcinomas is associated with mutation and immortalization of cell lines. J Clin Endocrinol Metab 81 (1996) 3498-3504
11. Goto A., Sakamoto A., and Machinami R. An immunohistochemical analysis of cyclin D1, p53 and p21waf1/cip1 proteins in tumors originating from the follicular epithelium of the thyroid gland. Pathol Res Pract 197 (2001) 217-222
12. Ohta K., Endo T., and Onaya T. The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues. Biochem Biophys Res Commun 174 (1991) 1148-1153
13. Haugen B.R., Nawaz S., Markham N., et al. Telomerase activity in benign and malignant thyroid tumors. Thyroid 7 (1997) 337-342
14. Umbricht C.B., Saji M., Westra W.H., Udelsman R., Zeiger M.A., and Sukumar S. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res 57 (1997) 2144-2147
15. Cheng A.J., Lin J.D., Chang T., and Wang T.C. Telomerase activity in benign and malignant human thyroid tissues. Br J Cancer 77 (1998) 2177-2180
16. Bornstein-Quevedo L., Garcia-Hernandez M.L., Camacho-Arroyo I., et al. Telomerase activity in well-differentiated papillary thyroid carcinoma correlates with advanced clinical stage of the disease. Endocr Pathol 14 (2003) 213-219
17. Kojima H., Yokosuka O., Imazeki F., Saisho H., and Omata H. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 112 (1997) 493-500
18. Yoshida K., Sugino T., Tahara H., et al. Telomerase activity in bladder carcinoma and its implication for non-invasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 79 (1997) 362-369
19. Albanell J., Lonardo F., Rusch V., et al. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J Natl Cancer Inst 89 (1997) 1609-1615
20. Herbert B.S., Wright W.E., and Shay J.W. Telomerase and breast cancer. Breast Cancer Res 3 (2001) 146-149
21. Hiyama E., Saeki T., Hiyama K., et al. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples. Cancer 90 (2000) 235-238
22. Wang Z., Ramin S.A., Tsai C., et al. Evaluation of PCR-ELISA for determination of telomerase activity in prostate needle biopsy and prostatic fluid specimens. Urol Oncol 7 (2002) 199-205
23. Sebesta J., Brown T., Williard W., et al. Does telomerase activity add to the value of fine needle aspirations in evaluating thyroid nodules?. Am J Surg 181 (2001) 420-422
24. Trulsson L.M., Velin A.K., Herder A., Soderkvist P., Ruter A., and Smeds S. Telomerase activity in surgical specimens and fine-needle aspiration biopsies from hyperplastic and neoplastic human thyroid tissues. Am J Surg 186 (2003) 83-88
25. Wu V.Y., Hruszkewycz A.M., Delgado R.M., et al. Limitation on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays. Clin Chim Acta 293 (2000) 199-212
26. Romano M., Grattone M., Karner M., et al. The relationship between the level of c-myc mRNA and histologic aggressiveness in thyroid tumors. Horm Res 39 (1993) 686-688
27. Brabant G., Maenhaut C., Kohrle J., et al. Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol 82 (1991) 7-12
28. Guerra L., Bover L., and Mordoh J. Differentiating effect of l-Tyrosine on the human melanoma cell line IIB-MEL. J Exp Cell Res 188 (1990) 61-65
29. Microcal™ Origin, Microcal Software Inc., Northamptom Maryland, 1999.
30. Suzuki S., Fukushima T., Ami H., Onogi H., Nakamura I., and Takenoshita S. New attempt of preoperative differential diagnosis of thyroid neoplasm by telomerase activity measurement. Oncol Rep 9 (2002) 539-544
31. Aogi K., Kitahara K., Buley I., et al. Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates. Clin Cancer Res 4 (1998) 1965-1970
32. Fedriga R., Gunelli R., Nanni O., Bacci F., Amadori D., and Calistri D. Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliation in urine. Neoplasia 3 (2001) 446-450
33. Kataki A., Sotirianakos S., Memos N., et al. P53 and C-FOS overexpression in patients with thyroid cancer: an immunohistochemical study. Neoplasma 50 (2003) 26-30
34. Bertaux F., Noel M., Malthiery Y., and Fragu P. Demonstration of a heterogeneous transcription pattern of thyroglobulin mRNA in human thyroid tissues. Biochem Biophys Res Commun 178 (1991) 586-592